Tag: SIMPLAAFY study
TCT 2026: Reduced-dose NOACs and aspirin non-inferior to DAPT for six-month...
Boston Scientific has announced positive six-month primary endpoint results from the SIMPLAAFY randomised controlled trial of the Watchman FLX Pro left atrial appendage closure...